{"hands_on_practices": [{"introduction": "Alexander Fleming's discovery began with a simple observation: a clear zone where bacteria failed to grow around a mold colony. This exercise challenges you to translate that seminal observation into a quantitative biophysical model. By applying the principles of diffusion, you will derive an expression for the size of the inhibition zone, linking it to the antibiotic's secretion rate, its diffusivity in the agar, and the bacteria's growth rate [@problem_id:4982103].", "problem": "Penicillin was discovered when a mold colony inhibited bacterial growth nearby. Consider a simplified, steady-state, spherically symmetric model of a penicillin-producing colony embedded in a homogeneous agar medium, intended to capture the essential physics and biology that set the size of the inhibition zone. A spherical colony of radius $a$ secretes penicillin at a uniform outward flux $q$ (amount per unit area per unit time) across its surface into the agar, where penicillin diffuses with diffusivity $D$. Assume that in the agar there is no bulk convection, no binding to the matrix, and no chemical decay of penicillin; further assume that susceptible bacteria are initially present everywhere outside the colony, but they do not consume penicillin in the region where they are inhibited and thus do not alter its distribution. In the absence of antibiotic, the bacteria would grow exponentially at per-capita rate $r$. Near the threshold of inhibition, model the antibiotic effect as a local per-capita kill rate proportional to the antibiotic concentration $C$, with proportionality coefficient $\\beta$ (so that the local net per-capita bacterial growth rate is $r - \\beta C$). Define the inhibition zone as the region where the net per-capita growth rate is nonpositive, and define the inhibition radius $R^{\\star}$ implicitly by the threshold condition $r = \\beta C(R^{\\star})$. Work in the steady state of antibiotic transport around the producer, and assume the agar extends effectively to infinity.\n\nUsing first-principles diffusion-reaction reasoning starting from the fundamental definitions of diffusive flux and mass balance, derive a closed-form analytic expression for the inhibition-zone diameter $d = 2 R^{\\star}$ in terms of $D$, $q$, $r$, $a$, and $\\beta$. Express your final answer as a single simplified analytical expression. Do not evaluate numerically and do not include units in the final expression.", "solution": "The user has provided a problem statement describing a simplified biophysical model of an antibiotic inhibition zone. I will first validate the problem's integrity and then, if it is valid, provide a complete derivation of the requested quantity.\n\n### Step 1: Extract Givens\n- **System:** Steady-state, spherically symmetric model.\n- **Colony:** Spherical, radius $a$.\n- **Secretion:** Uniform outward flux $q$ (amount per unit area per unit time) at the colony surface $r=a$.\n- **Medium:** Homogeneous agar, extending to infinity.\n- **Transport:** Diffusion with diffusivity $D$.\n- **Transport Assumptions:** No bulk convection, no binding to agar, no chemical decay of the antibiotic (penicillin).\n- **Concentration:** Penicillin concentration is denoted by $C(r)$.\n- **Bacteria:** Susceptible bacteria are initially present for $r>a$. They do not consume the antibiotic in the inhibited region.\n- **Bacterial Growth:** Net per-capita growth rate is given by $r - \\beta C$, where $r$ is the intrinsic growth rate and $\\beta$ is a proportionality coefficient for the antibiotic-induced kill rate.\n- **Inhibition Condition:** The inhibition zone is where the net growth rate is nonpositive, i.e., $r - \\beta C \\le 0$.\n- **Inhibition Radius ($R^{\\star}$):** The outer boundary of the inhibition zone, implicitly defined by the threshold condition $r = \\beta C(R^{\\star})$.\n- **Objective:** Derive a closed-form analytic expression for the inhibition-zone diameter $d = 2 R^{\\star}$ in terms of $D$, $q$, $r$, $a$, and $\\beta$.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The problem is based on Fick's laws of diffusion, a cornerstone of physical chemistry and transport phenomena. The reaction-diffusion model, though simplified, is a standard approach in mathematical biology to describe such phenomena. The assumptions (steady state, spherical symmetry, no decay) are common idealizations used to make the problem analytically tractable. Therefore, the problem is scientifically sound.\n- **Well-Posed:** The problem provides a governing partial differential equation (the diffusion equation), which simplifies to an ordinary differential equation under the given symmetries. It also provides two boundary conditions (a flux condition at $r=a$ and an implicit condition at $r \\to \\infty$), which are sufficient to determine the unique solution for the concentration profile $C(r)$. The final condition, $r = \\beta C(R^{\\star})$, allows for the determination of the specific radius $R^{\\star}$. The problem is well-posed.\n- **Objective:** The problem is stated using precise, quantitative language. All parameters are explicitly defined. There is no subjective or ambiguous terminology.\n- **Flaw Checklist:** A check against the list of potential flaws reveals no issues. The problem does not violate scientific principles, is formalizable, is self-contained, describes a physically plausible (though idealized) scenario, is well-structured, and is not trivial.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid**. I will proceed to derive the solution.\n\n### Derivation\nThe problem asks for the steady-state concentration profile of penicillin, $C(r)$, in the agar medium for $r \\ge a$. The transport is governed by diffusion. Since there is no consumption or decay of penicillin in the medium, the governing equation is the steady-state diffusion equation, which in the absence of sources or sinks in the volume of the medium is $D \\nabla^2 C = 0$.\n\nGiven the spherical symmetry of the problem, the concentration $C$ is a function of the radial coordinate $r$ only. The Laplacian operator $\\nabla^2$ in spherical coordinates simplifies to:\n$$ \\nabla^2 C(r) = \\frac{1}{r^2} \\frac{d}{dr} \\left( r^2 \\frac{dC}{dr} \\right) $$\nThus, the governing differential equation for $r > a$ is:\n$$ D \\frac{1}{r^2} \\frac{d}{dr} \\left( r^2 \\frac{dC}{dr} \\right) = 0 $$\nSince the diffusivity $D$ is a non-zero constant, we can divide by it:\n$$ \\frac{d}{dr} \\left( r^2 \\frac{dC}{dr} \\right) = 0 $$\nIntegrating this equation once with respect to $r$ yields:\n$$ r^2 \\frac{dC}{dr} = K_1 $$\nwhere $K_1$ is a constant of integration. Rearranging for $\\frac{dC}{dr}$:\n$$ \\frac{dC}{dr} = \\frac{K_1}{r^2} $$\nIntegrating a second time with respect to $r$ gives the general solution for the concentration profile:\n$$ C(r) = \\int \\frac{K_1}{r^2} dr = -\\frac{K_1}{r} + K_2 $$\nwhere $K_2$ is a second constant of integration.\n\nTo determine the constants $K_1$ and $K_2$, we must apply the boundary conditions provided in the problem.\n\n**Boundary Condition 1: Flux at the colony surface ($r=a$)**\nThe problem states that there is a uniform outward flux $q$ at the surface of the colony. The diffusive flux, $\\vec{J}$, is given by Fick's first law: $\\vec{J} = -D \\nabla C$. In spherical coordinates, the radial component of the flux is $J_r = -D \\frac{dC}{dr}$.\nAt $r=a$, the radial flux is given as $q$. Therefore:\n$$ J_r(a) = q = -D \\left. \\frac{dC}{dr} \\right|_{r=a} $$\nSubstituting our expression for $\\frac{dC}{dr}$:\n$$ q = -D \\left( \\frac{K_1}{a^2} \\right) $$\nSolving for $K_1$:\n$$ K_1 = -\\frac{q a^2}{D} $$\n\n**Boundary Condition 2: Concentration at infinity ($r \\to \\infty$)**\nThe agar medium extends to infinity, and the only source of penicillin is the finite-sized colony. It is physically necessary that the concentration of penicillin due to the colony should vanish at an infinite distance from the source.\n$$ \\lim_{r \\to \\infty} C(r) = 0 $$\nApplying this condition to our general solution:\n$$ \\lim_{r \\to \\infty} \\left( -\\frac{K_1}{r} + K_2 \\right) = 0 + K_2 = K_2 $$\nThus, we find that $K_2 = 0$.\n\nNow we can substitute the determined values of $K_1$ and $K_2$ back into the general solution to obtain the specific concentration profile for $r \\ge a$:\n$$ C(r) = -\\frac{\\left(-\\frac{q a^2}{D}\\right)}{r} + 0 $$\n$$ C(r) = \\frac{q a^2}{D r} $$\n\nThe final step is to determine the inhibition-zone diameter, $d$. The inhibition radius, $R^{\\star}$, is defined by the condition where the net bacterial growth rate is zero:\n$$ r - \\beta C(R^{\\star}) = 0 \\implies r = \\beta C(R^{\\star}) $$\nSubstituting our expression for $C(r)$:\n$$ r = \\beta \\left( \\frac{q a^2}{D R^{\\star}} \\right) $$\nWe can now solve this algebraic equation for $R^{\\star}$:\n$$ R^{\\star} = \\frac{\\beta q a^2}{D r} $$\nThe problem asks for the inhibition-zone diameter, $d$, which is twice the inhibition radius:\n$$ d = 2 R^{\\star} $$\nSubstituting the expression for $R^{\\star}$:\n$$ d = 2 \\left( \\frac{\\beta q a^2}{D r} \\right) $$\n$$ d = \\frac{2 \\beta q a^2}{D r} $$\nThis expression gives the diameter of the inhibition zone in terms of the specified parameters.", "answer": "$$\\boxed{\\frac{2 \\beta q a^{2}}{D r}}$$", "id": "4982103"}, {"introduction": "The effectiveness of antibiotics is constantly challenged by the evolution of resistant bacterial strains. To understand and predict this process, we must quantify the evolutionary advantage, or \"fitness,\" that resistance confers. This practice guides you to derive the selection coefficient, $s$, a cornerstone concept in population genetics, directly from the net growth rates of susceptible and resistant bacteria, providing a precise mathematical tool to analyze the dynamics of resistance [@problem_id:4982070].", "problem": "Consider two bacterial subpopulations in a well-mixed, constant environment containing a fixed concentration of an antibiotic: a drug-susceptible subpopulation, denoted by $S$, and a drug-resistant subpopulation, denoted by $R$. Assume the population is sufficiently dilute that density-dependent effects are negligible, and that per-capita birth and death processes are memoryless with constant rates under the drug. For each subpopulation $i \\in \\{S, R\\}$, let the per-capita birth rate be $b_i$ and the per-capita death rate be $d_i$. The net per-capita growth rate is defined by $g_i = b_i - d_i$. Under these assumptions, the abundance $N_i(t)$ of each subpopulation obeys the exponential growth law $N_i(t) = N_i(0)\\exp(g_i t)$.\n\nUsing only these foundational definitions, formulate a mathematically precise definition of the selection coefficient $s$ that quantifies the instantaneous growth advantage of the resistant subpopulation $R$ over the susceptible subpopulation $S$ under the antibiotic. Starting from the exponential growth law and the definition of net growth rate, derive how $s$ depends on the difference in net growth rates under the drug.\n\nThen, using the following scientifically plausible rates measured under the antibiotic,\n$b_R = 0.90\\,\\text{h}^{-1}$, $d_R = 0.60\\,\\text{h}^{-1}$, $b_S = 0.85\\,\\text{h}^{-1}$, and $d_S = 1.05\\,\\text{h}^{-1}$, compute the numerical value of $s$ implied by your derivation. Express your final answer in $\\text{h}^{-1}$. If rounding is needed, round your answer to four significant figures.", "solution": "The problem is validated as being scientifically grounded, well-posed, and objective. It presents a standard model from population dynamics and asks for a derivation and calculation based on the provided principles and data. All necessary information is supplied, and there are no contradictions or ambiguities.\n\nThe problem requires the formulation of a definition for the selection coefficient, $s$, which quantifies the growth advantage of a resistant subpopulation ($R$) over a susceptible subpopulation ($S$). The dynamics of each subpopulation $i \\in \\{S, R\\}$ are given by the exponential growth law:\n$$N_i(t) = N_i(0)\\exp(g_i t)$$\nwhere $N_i(t)$ is the abundance at time $t$, $N_i(0)$ is the initial abundance, and $g_i$ is the net per-capita growth rate. The net growth rate is defined as the difference between the per-capita birth rate, $b_i$, and the per-capita death rate, $d_i$:\n$$g_i = b_i - d_i$$\n\nThe selection coefficient, $s$, is a measure of the relative fitness difference. In the context of competing populations, it is standard to define this based on the rate of change of the ratio of their abundances. Let us define the ratio of the resistant subpopulation abundance to the susceptible subpopulation abundance as $z(t)$:\n$$z(t) = \\frac{N_R(t)}{N_S(t)}$$\nIf the resistant subpopulation has a growth advantage, this ratio will increase over time. The selection coefficient $s$ is formally defined as the proportional rate of change of this ratio $z(t)$. Mathematically, this definition is:\n$$s = \\frac{1}{z(t)}\\frac{dz(t)}{dt}$$\n\nTo derive how $s$ depends on the net growth rates, we substitute the exponential growth laws into the expression for $z(t)$:\n$$z(t) = \\frac{N_R(0)\\exp(g_R t)}{N_S(0)\\exp(g_S t)}$$\nThis can be rewritten by grouping the initial terms and the exponential terms:\n$$z(t) = \\frac{N_R(0)}{N_S(0)} \\exp((g_R - g_S)t)$$\nLet $z(0) = \\frac{N_R(0)}{N_S(0)}$ be the initial ratio. The expression becomes:\n$$z(t) = z(0) \\exp((g_R - g_S)t)$$\nNow, we differentiate $z(t)$ with respect to time $t$ using the chain rule:\n$$\\frac{dz(t)}{dt} = \\frac{d}{dt} \\left[ z(0) \\exp((g_R - g_S)t) \\right]$$\n$$\\frac{dz(t)}{dt} = z(0) \\cdot (g_R - g_S) \\cdot \\exp((g_R - g_S)t)$$\nWe can recognize that the term $z(0) \\exp((g_R - g_S)t)$ is simply $z(t)$. Therefore, we can substitute $z(t)$ back into the equation:\n$$\\frac{dz(t)}{dt} = (g_R - g_S) z(t)$$\nThis equation shows that the rate of change of the ratio $z(t)$ is directly proportional to the ratio itself, with the constant of proportionality being the difference in the net growth rates.\n\nFinally, we use our formal definition of the selection coefficient, $s$:\n$$s = \\frac{1}{z(t)}\\frac{dz(t)}{dt}$$\nSubstituting the expression we just derived for $\\frac{dz(t)}{dt}$:\n$$s = \\frac{1}{z(t)} \\left[ (g_R - g_S) z(t) \\right]$$\nThe term $z(t)$ cancels, yielding the relationship between the selection coefficient and the net growth rates:\n$$s = g_R - g_S$$\nThis derivation shows that for populations undergoing exponential growth, the selection coefficient is precisely the difference between their net per-capita growth rates.\n\nThe problem provides the following specific rates under antibiotic pressure:\n$b_R = 0.90\\,\\text{h}^{-1}$ (Resistant birth rate)\n$d_R = 0.60\\,\\text{h}^{-1}$ (Resistant death rate)\n$b_S = 0.85\\,\\text{h}^{-1}$ (Susceptible birth rate)\n$d_S = 1.05\\,\\text{h}^{-1}$ (Susceptible death rate)\n\nFirst, we calculate the net per-capita growth rates for each subpopulation.\nFor the resistant subpopulation, $R$:\n$$g_R = b_R - d_R = 0.90\\,\\text{h}^{-1} - 0.60\\,\\text{h}^{-1} = 0.30\\,\\text{h}^{-1}$$\nFor the susceptible subpopulation, $S$:\n$$g_S = b_S - d_S = 0.85\\,\\text{h}^{-1} - 1.05\\,\\text{h}^{-1} = -0.20\\,\\text{h}^{-1}$$\nA negative net growth rate for the susceptible population is expected in the presence of an effective antibiotic.\n\nNow, we compute the selection coefficient $s$ using the derived formula:\n$$s = g_R - g_S = (0.30\\,\\text{h}^{-1}) - (-0.20\\,\\text{h}^{-1})$$\n$$s = 0.30\\,\\text{h}^{-1} + 0.20\\,\\text{h}^{-1} = 0.50\\,\\text{h}^{-1}$$\nThe problem requires the answer to be expressed to four significant figures if rounding is needed. The calculation is exact. To adhere to the specified precision, we write the result with four significant figures.\n$$s = 0.5000\\,\\text{h}^{-1}$$", "answer": "$$\\boxed{0.5000}$$", "id": "4982070"}, {"introduction": "Administering the right amount of an antibiotic is not enough; it must be given at the right frequency to be effective. This clinical challenge is at the heart of pharmacokinetics and pharmacodynamics (PK/PD), which you will explore by modeling the concentration of a beta-lactam antibiotic in a patient over time. By deriving the relationship from first principles, you will calculate a crucial therapeutic target, the fraction of time the drug concentration remains above the minimum inhibitory concentration ($fT > \\text{MIC}$), and understand how dosing schedules directly impact treatment success [@problem_id:4982038].", "problem": "A new beta-lactam antibiotic is being evaluated for dosing regimen optimization in the context of its pharmacokinetic-pharmacodynamic relationship. For time-dependent antibiotics such as beta-lactams, efficacy correlates with the fraction of the dosing interval during which the free (unbound) plasma concentration exceeds the Minimum Inhibitory Concentration (MIC), denoted as $fT > \\text{MIC}$. Consider a one-compartment pharmacokinetic model with first-order elimination, where following an instantaneous intravenous bolus dose the plasma concentration is $C(t)=C_{0}\\exp(-kt)$, with $C_{0}=\\text{Dose}/V_{d}$ and $k=\\ln(2)/t_{1/2}$. Assume linear kinetics, immediate mixing, no absorption phase, and that steady state has been reached under repeated dosing.\n\nA $70$ kg adult receives the antibiotic as an intravenous bolus at a dose of $1\\,\\text{g}$ every $12$ h (twice-daily dosing). The volume of distribution is $V_{d}=20\\,\\text{L}$, the elimination half-life is $t_{1/2}=3\\,\\text{h}$, and the unbound (free) fraction is $f_{u}=0.70$. The pathogenâ€™s Minimum Inhibitory Concentration (MIC) is $\\text{MIC}=8\\,\\text{mg}\\,\\text{L}^{-1}$.\n\nStarting from the one-compartment model and fundamental principles (first-order elimination and linear superposition at steady state), derive the steady-state free concentration over a dosing interval and compute $fT > \\text{MIC}$ for the twice-daily regimen as a decimal fraction. Express the final $fT > \\text{MIC}$ value as a unitless decimal and round your answer to four significant figures. Also, in your working, explain briefly how the dosing interval modifies target attainment in this framework without using any pre-memorized shortcut formulas beyond the stated model.", "solution": "The problem is subjected to validation prior to any solution attempt.\n\n### Step 1: Extract Givens\n- **Model**: One-compartment pharmacokinetic model, first-order elimination.\n- **Concentration Profile (Single Dose)**: $C(t)=C_{0}\\exp(-kt)$\n- **Initial Concentration**: $C_{0}=\\text{Dose}/V_{d}$\n- **Elimination Rate Constant**: $k=\\ln(2)/t_{1/2}$\n- **Pharmacokinetic State**: Steady state under repeated dosing.\n- **Dosing Regimen**: Dose $= 1\\,\\text{g}$, Dosing interval $\\tau = 12\\,\\text{h}$.\n- **Volume of Distribution**: $V_{d}=20\\,\\text{L}$\n- **Elimination Half-Life**: $t_{1/2}=3\\,\\text{h}$\n- **Unbound Fraction**: $f_{u}=0.70$\n- **Minimum Inhibitory Concentration**: $\\text{MIC}=8\\,\\text{mg}\\,\\text{L}^{-1}$\n- **Target Parameter**: $fT > \\text{MIC}$, the fraction of the dosing interval where free plasma concentration exceeds the MIC.\n- **Required Output**: A decimal fraction rounded to four significant figures.\n- **Additional Requirement**: Derive the steady-state free concentration from first principles and explain the impact of the dosing interval on target attainment.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is well-defined and scientifically sound.\n- **Scientifically Grounded**: The one-compartment model with first-order elimination is a fundamental and standard model in pharmacokinetics. The concept of $fT > \\text{MIC}$ is a critical, validated pharmacodynamic index for time-dependent antibiotics like beta-lactams.\n- **Well-Posed**: All necessary parameters (Dose, $V_d$, $t_{1/2}$, $\\tau$, $f_u$, MIC) are provided to uniquely determine the solution. The instructions are clear.\n- **Objective**: The problem is stated using precise, quantitative, and unbiased language.\n- **Consistency**: The provided data are internally consistent and physically plausible. For instance, a $1\\,\\text{g}$ dose, $20\\,\\text{L}$ volume of distribution, and $3\\,\\text{h}$ half-life are realistic clinical values. The units are consistent, although a conversion from g to mg is required. The patient weight of $70$ kg is extraneous information as $V_d$ is given as an absolute volume, but it does not create a contradiction.\n\n### Step 3: Verdict and Action\nThe problem is valid. A full solution will be derived.\n\n### Solution Derivation\nThe primary objective is to calculate $fT > \\text{MIC}$, the fraction of the dosing interval $\\tau$ during which the free, unbound drug concentration $C_u(t)$ is greater than the Minimum Inhibitory Concentration (MIC).\n\nFirst, we define and calculate the necessary parameters.\n- Dose: $D = 1\\,\\text{g} = 1000\\,\\text{mg}$.\n- Dosing Interval: $\\tau = 12\\,\\text{h}$.\n- Volume of Distribution: $V_d = 20\\,\\text{L}$.\n- Elimination Half-Life: $t_{1/2} = 3\\,\\text{h}$.\n- Unbound Fraction: $f_u = 0.70$.\n- Minimum Inhibitory Concentration: $\\text{MIC} = 8\\,\\text{mg}\\,\\text{L}^{-1}$.\n\nThe elimination rate constant, $k$, is calculated from the half-life:\n$$k = \\frac{\\ln(2)}{t_{1/2}} = \\frac{\\ln(2)}{3}\\,\\text{h}^{-1}$$\nThe concentration immediately following a single intravenous bolus dose, $C_0$, is:\n$$C_0 = \\frac{D}{V_d} = \\frac{1000\\,\\text{mg}}{20\\,\\text{L}} = 50\\,\\text{mg}\\,\\text{L}^{-1}$$\n\nThe problem requires deriving the steady-state concentration from first principles. At steady state, the concentration profile over a dosing interval, $\\tau$, is periodic. Let $C_{ss,max}$ be the peak concentration immediately after a dose, and $C_{ss,min}$ be the trough concentration immediately before the next dose.\nThe relationship between peak and trough is governed by first-order elimination over the interval $\\tau$:\n$$C_{ss,min} = C_{ss,max} \\exp(-k\\tau)$$\nAt steady state, the concentration immediately after a dose is the sum of the trough concentration and the concentration boost from the new dose, $C_0$:\n$$C_{ss,max} = C_{ss,min} + C_0$$\nWe solve this system of two linear equations. Substituting the second equation into the first:\n$$C_{ss,min} = (C_{ss,min} + C_0) \\exp(-k\\tau)$$\n$$C_{ss,min} = C_{ss,min} \\exp(-k\\tau) + C_0 \\exp(-k\\tau)$$\n$$C_{ss,min} (1 - \\exp(-k\\tau)) = C_0 \\exp(-k\\tau)$$\n$$C_{ss,min} = \\frac{C_0 \\exp(-k\\tau)}{1 - \\exp(-k\\tau)}$$\nNow, we find the peak concentration, $C_{ss,max}$:\n$$C_{ss,max} = C_{ss,min} + C_0 = \\frac{C_0 \\exp(-k\\tau)}{1 - \\exp(-k\\tau)} + C_0 = \\frac{C_0 \\exp(-k\\tau) + C_0(1 - \\exp(-k\\tau))}{1 - \\exp(-k\\tau)} = \\frac{C_0}{1 - \\exp(-k\\tau)}$$\nThe concentration at any time $t$ within the dosing interval ($0 \\le t \\le \\tau$), starting from the peak at $t=0$, is:\n$$C_{ss}(t) = C_{ss,max} \\exp(-kt)$$\nThe pharmacologically active concentration is the free (unbound) concentration, $C_{u,ss}(t)$, given by:\n$$C_{u,ss}(t) = f_u C_{ss}(t) = f_u C_{ss,max} \\exp(-kt)$$\nThe target is to find the duration $t^*$ for which $C_{u,ss}(t) > \\text{MIC}$. This duration starts at $t=0$ (the peak) and ends when the concentration falls to the MIC value. We find $t^*$ by setting $C_{u,ss}(t^*) = \\text{MIC}$.\n$$f_u C_{ss,max} \\exp(-kt^*) = \\text{MIC}$$\nBefore solving for $t^*$, we must verify that the free peak concentration, $C_{u,ss,max}=f_u C_{ss,max}$, is above the MIC, and the free trough concentration, $C_{u,ss,min}=f_u C_{ss,min}$, is below the MIC. if the trough were above the MIC, time above MIC would be $100\\%$. If the peak were below, it would be $0\\%$.\n\nLet's compute the values:\nThe product $k\\tau$ is:\n$$k\\tau = \\left(\\frac{\\ln(2)}{3\\,\\text{h}}\\right) (12\\,\\text{h}) = 4\\ln(2) = \\ln(2^4) = \\ln(16)$$\nThe factor $1 - \\exp(-k\\tau)$ is:\n$$1 - \\exp(-\\ln(16)) = 1 - \\frac{1}{16} = \\frac{15}{16}$$\nNow, we calculate $C_{ss,max}$:\n$$C_{ss,max} = \\frac{C_0}{1 - \\exp(-k\\tau)} = \\frac{50\\,\\text{mg}\\,\\text{L}^{-1}}{15/16} = \\frac{50 \\times 16}{15}\\,\\text{mg}\\,\\text{L}^{-1} = \\frac{10 \\times 16}{3}\\,\\text{mg}\\,\\text{L}^{-1} = \\frac{160}{3}\\,\\text{mg}\\,\\text{L}^{-1}$$\nThe peak unbound concentration is:\n$$C_{u,ss,max} = f_u C_{ss,max} = 0.70 \\times \\frac{160}{3}\\,\\text{mg}\\,\\text{L}^{-1} = \\frac{7}{10} \\times \\frac{160}{3}\\,\\text{mg}\\,\\text{L}^{-1} = \\frac{7 \\times 16}{3}\\,\\text{mg}\\,\\text{L}^{-1} = \\frac{112}{3}\\,\\text{mg}\\,\\text{L}^{-1} \\approx 37.33\\,\\text{mg}\\,\\text{L}^{-1}$$\nSince $C_{u,ss,max} \\approx 37.33\\,\\text{mg}\\,\\text{L}^{-1} > \\text{MIC} = 8\\,\\text{mg}\\,\\text{L}^{-1}$, the concentration does exceed the MIC.\nThe trough unbound concentration is:\n$$C_{u,ss,min} = C_{u,ss,max} \\exp(-k\\tau) = \\frac{112}{3} \\exp(-\\ln(16)) = \\frac{112}{3} \\times \\frac{1}{16} = \\frac{7}{3}\\,\\text{mg}\\,\\text{L}^{-1} \\approx 2.33\\,\\text{mg}\\,\\text{L}^{-1}$$\nSince $C_{u,ss,min} \\approx 2.33\\,\\text{mg}\\,\\text{L}^{-1} < \\text{MIC} = 8\\,\\text{mg}\\,\\text{L}^{-1}$, the concentration drops below the MIC during the interval.\n\nNow we solve for $t^*$:\n$$\\exp(-kt^*) = \\frac{\\text{MIC}}{f_u C_{ss,max}}$$\n$$-kt^* = \\ln\\left(\\frac{\\text{MIC}}{f_u C_{ss,max}}\\right)$$\n$$t^* = \\frac{1}{k} \\ln\\left(\\frac{f_u C_{ss,max}}{\\text{MIC}}\\right)$$\nSubstituting the values:\n$$t^* = \\frac{1}{(\\ln(2)/3)} \\ln\\left(\\frac{112/3}{8}\\right) = \\frac{3}{\\ln(2)} \\ln\\left(\\frac{112}{24}\\right) = \\frac{3}{\\ln(2)} \\ln\\left(\\frac{14}{3}\\right)$$\nThe fraction of the dosing interval above MIC, $fT > \\text{MIC}$, is $t^*/\\tau$:\n$$fT > \\text{MIC} = \\frac{t^*}{\\tau} = \\frac{1}{12} \\left( \\frac{3}{\\ln(2)} \\ln\\left(\\frac{14}{3}\\right) \\right) = \\frac{1}{4\\ln(2)} \\ln\\left(\\frac{14}{3}\\right) = \\frac{\\ln(14/3)}{\\ln(16)}$$\nNumerically, this value is:\n$$fT > \\text{MIC} = \\frac{\\ln(14/3)}{\\ln(16)} \\approx \\frac{1.540445}{2.772589} \\approx 0.55562$$\nRounding to four significant figures, we get $0.5556$. This means the free concentration is above the MIC for approximately $55.56\\%$ of the dosing interval.\n\nRegarding the role of the dosing interval $\\tau$: the expression for target attainment is $fT > \\text{MIC} = \\frac{1}{\\tau k} \\ln\\left(\\frac{f_u C_0}{(1-\\exp(-k\\tau))\\text{MIC}}\\right)$. Keeping the dose-per-administration $D$ constant, increasing the dosing interval $\\tau$ (less frequent dosing) adversely affects target attainment. A larger $\\tau$ leads to a smaller accumulation factor $1/(1-\\exp(-k\\tau))$, which lowers the peak steady-state concentration $C_{ss,max}$. Consequently, the trough concentration $C_{ss,min}$ drops even more significantly. This increased fluctuation (lower peaks and much lower troughs) means the concentration profile spends a proportionally smaller fraction of time above the MIC, thus reducing $fT > \\text{MIC}$. For time-dependent antibiotics, shorter intervals (more frequent dosing), which maintain concentrations more consistently above the MIC, are generally more effective.", "answer": "$$\\boxed{0.5556}$$", "id": "4982038"}]}